Dow slides 391 points on reports Moderna’s COVID-19 vaccine study lacked key data

(May 20 04:07) Businessinsider.sg

Markets turned lower Tuesday afternoon after STAT News reported the company's update didn't include data critical to judging the treatment's success.

You can find the original article here